Literature DB >> 9655873

Regulation of organic cation transport in IHKE-1 and LLC-PK1 cells. Fluorometric studies with 4-(4-dimethylaminostyryl)-N-methylpyridinium.

H Hohage1, A Stachon, C Feidt, J R Hirsch, E Schlatter.   

Abstract

The regulation of transport of the fluorescent organic cation 4-(4-dimethylaminostyryl)-N-methylpyridinium (ASP+) by renal proximal tubular organic cation transport was studied in IHKE-1 and LLC-PK1 cells with a recently established fluorometric technique (Stachon et al., 1996, 1997). Stimulation of Ca++/diacylglycerol-dependent protein kinase by 1,2-dioctanoyl glycerol (DOG; 0.01-1 mumol/l, n = 7), ATP (0.1 mmol/l, n = 9), oxytocin (0.1 mumol/l, n = 6) and bradykinin (1 mumol/l, n = 7) resulted in an increase of ASP+ accumulation in IHKE-1 cells by 35 +/- 9% (DOG), 65 +/- 30% (ATP), 66 +/- 14% (bradykinin) and 70 +/- 20% (oxytocin) as compared with basal conditions, whereas ASP+ accumulation was slightly reduced in LLC-PK1 cells after stimulation with DOG (1 mumol/l, -20 +/- 7%, n = 10) and angiotensin II (0.1 nmol/l, -20 +/- 5%, n = 6). ASP+ accumulation in IHKE-1 cells also was increased by 0.5 mumol/l (20 +/- 8%, n = 8) and 1 mumol/l forskolin (35 +/- 13%, n = 19), and by 8-bromo-cAMP (1 mumol/l, 125 +/- 25%, n = 9), both activators of the cAMP-dependent protein kinase (PKA). Activation of the cGMP-dependent protein kinase (PKG) by human atrial natriuretic peptide (10 nmol/l, n = 10) or 8-bromo-cGMP (0.1 mmol/l, n = 12) resulted in an increase of 35 +/- 5% and 28 +/- 6%, respectively. Activation of PKA and PKG had no influence on ASP+ transport in LLC-PK1 cells. Regulation of ASP+ uptake by these two cell lines may be caused by direct phosphorylation of the organic cation transporters involved or by regulation of trafficking of the transporters to the membrane. Differences in the organic cation transporter isoforms or alternatively, in the trafficking may contribute to the distinct regulation of ASP+ transport in IHKE-1 and LLC-PK1 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655873

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

2.  A novel cGMP-regulated K+ channel in immortalized human kidney epitheliall cells (IHKE-1).

Authors:  J R Hirsch; G Weber; I Kleta; E Schlatter
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

3.  Regulation of human organic anion transporter 3 by peptide hormone bradykinin.

Authors:  Shanshan Li; Peng Duan; Guofeng You
Journal:  J Pharmacol Exp Ther       Date:  2010-03-18       Impact factor: 4.030

4.  4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP+) is a fluorescent substrate for the human serotonin transporter.

Authors:  Ernesto Solis; Igor Zdravkovic; Ian D Tomlinson; Sergei Y Noskov; Sandra J Rosenthal; Louis J De Felice
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

5.  Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system.

Authors:  Katrin Guske; Boris Schmitz; Michael Schelleckes; Kerstin Duning; Joachim Kremerskothen; Hermann J Pavenstädt; Stefan-Martin Brand; Eva Brand
Journal:  J Mol Med (Berl)       Date:  2013-09-27       Impact factor: 4.599

6.  Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A -10T genotype.

Authors:  Michael Schelleckes; Malte Lenders; Katrin Guske; Boris Schmitz; Christian Tanislav; Sonja Ständer; Dieter Metze; Istvan Katona; Joachim Weis; Stefan-Martin Brand; Thomas Duning; Eva Brand
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

7.  ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA.

Authors:  Katrin Schelleckes; Boris Schmitz; Malte Lenders; Mirja Mewes; Stefan-Martin Brand; Eva Brand
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

8.  Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma.

Authors:  Katrin Schelleckes; Boris Schmitz; Giuliano Ciarimboli; Malte Lenders; Hermann J Pavenstädt; Edwin Herrmann; Stefan-Martin Brand; Eva Brand
Journal:  Clin Epigenetics       Date:  2017-10-06       Impact factor: 6.551

9.  The Probe for Renal Organic Cation Secretion (4-Dimethylaminostyryl)-N-Methylpyridinium (ASP+)) Shows Amplified Fluorescence by Binding to Albumin and Is Accumulated In Vivo.

Authors:  Jacob Schade Engbjerg; Vincenzo Costanzo; Donato Sardella; Luca Bordoni; Steen Jakobsen; Luciano D'Apolito; Jørgen Frøkiær; Francesco Trepiccione; Giovambattista Capasso; Sebastian Frische
Journal:  Mol Imaging       Date:  2022-03-22       Impact factor: 4.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.